XML 70 R59.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCKHOLDERS' EQUITY, Restricted Stock and Stock Options (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2021
USD ($)
Plan
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Jun. 16, 2020
shares
Stockholders' Equity Note Details [Abstract]          
Number of stock incentive plans | Plan 3        
Shares [Abstract]          
Outstanding, beginning balance (in shares) 81,000 116,000 139,000    
Canceled (in shares) 0 (35,000) (23,000)    
Outstanding, ending balance (in shares) 81,000 81,000 116,000 139,000  
Vested (in shares) 81,000        
Exercisable (in shares) 81,000        
Weighted Average Exercise Price Per Share [Abstract]          
Outstanding, beginning balance (in dollars per share) | $ / shares $ 7.79 $ 10.56 $ 12.14    
Canceled (in dollars per share) | $ / shares 0 16.95 20.15    
Outstanding, ending balance (in dollars per share) | $ / shares 7.79 $ 7.79 $ 10.56 $ 12.14  
Vested (in dollars per share) | $ / shares 7.79        
Exercisable (in dollars per share) | $ / shares $ 7.79        
Weighted Average Remaining Contractual Term [Abstract]          
Outstanding, balance 2 months 1 day 1 year 2 months 1 day 1 year 9 months 29 days 2 years 6 months 10 days  
Vested 2 months 1 day        
Exercisable, ending balance 2 months 1 day        
Aggregate Intrinsic Value [Abstract]          
Outstanding, beginning balance | $ $ 0 $ 0 $ 0    
Cancelled | $   0 0    
Outstanding, ending balance | $ 0 $ 0 $ 0 $ 0  
Vested | $ 0        
Exercisable | $ $ 0        
Restricted Stock [Member]          
Shares [Abstract]          
Nonvested restricted stock outstanding, beginning balance (in shares) 1,572,159 595,426      
Granted (in shares) 679,331 1,319,734      
Cancelled (in shares) 0 0      
Vested (in shares) (507,644) (343,001)      
Nonvested restricted stock outstanding, ending balance (in shares) 1,743,846 1,572,159 595,426    
Weighted Average Grant Date Fair Value Per Share [Abstract]          
Nonvested restricted stock outstanding, beginning balance (in dollars per share) | $ / shares $ 2.77 $ 3.15      
Granted (in dollars per share) | $ / shares 5.99 2.68      
Cancelled (in dollars per share) | $ / shares 0 0      
Vested (in dollars per share) | $ / shares 3.30 3.40      
Nonvested restricted stock outstanding, ending balance (in dollars per share) | $ / shares $ 3.89 $ 2.77 $ 3.15    
Recognized restricted stock expense | $ $ 2,900 $ 1,700      
Unrecognized restricted stock expense | $ 4,400 $ 3,200      
Stock Options [Member]          
Aggregate Intrinsic Value [Abstract]          
Unrecognized pre-tax compensation expense | $ $ 0        
2020 Plan [Member]          
Stockholders' Equity Note Details [Abstract]          
Number of shares available for issuance under incentive plan (in shares)         2,000,000
2020 Plan [Member] | June 16, 2020 [Member]          
Stockholders' Equity Note Details [Abstract]          
Stock option award issuance, plan duration 10 years        
LTIP [Member]          
Stockholders' Equity Note Details [Abstract]          
Number of shares available for issuance under incentive plan (in shares)         2,000,000
LTIP [Member] | Restricted Stock [Member]          
Weighted Average Grant Date Fair Value Per Share [Abstract]          
Outstanding restricted shares, intrinsic value | $ $ 13,000        
Non Employee Directors Plan [Member]          
Stockholders' Equity Note Details [Abstract]          
Net share settlement for restricted stock (in shares) 154,973 75,115      
Decrease in equity due to payment of tax for employee | $ $ 1,000        
Non Employee Directors Plan [Member] | Maximum [Member]          
Stockholders' Equity Note Details [Abstract]          
Decrease in equity due to payment of tax for employee | $   $ 200